Anew Health Ltd. (AVG) is poised to raise $9 million through an initial public offering (IPO) scheduled for November 21, 2025. The company plans to issue 1.8 million shares, priced between $4.00 and $6.00 per share, according to IPO Scoop.
Founded in 2007, Anew Health operates from Hong Kong and specializes in pain management and health services. The firm has reported significant financial performance, generating $40.02 million in revenue and $5.54 million in net income for the fiscal year ending March 31, 2025. With a current market capitalization of $259 million, the company aims to leverage the IPO to expand its operations.
Company Overview and Services
Anew Health Ltd. describes itself as a provider of non-invasive and non-pharmacological pain management treatments, marketed under its brand ANKH, which stands for “A New Key to Health.” The company emphasizes its mission to alleviate physical pain while promoting overall health and vitality.
The organization offers a comprehensive range of therapies, including functional enhancement treatments and dietary supplements. Its innovative RDS+ (Restore, Detox, and Strengthen) approach combines principles of Traditional Chinese Medicine (TCM) with advanced technology. By employing energy-based treatment devices such as lasers, bioelectrical currents, and ultrasound, Anew Health aims to address both the symptoms and root causes of pain.
According to the company’s description, the foundation of their therapies is rooted in the TCM concept of the meridian system, which posits that the flow of vital energy, or Qi, is crucial for health. The stagnation or blockage of Qi is believed to lead to pain and illness. Anew Health’s treatments focus on enhancing this flow to alleviate various conditions, including musculoskeletal pain and fatigue.
Investment Details and Future Outlook
D. Boral Capital, previously known as EF Hutton, is serving as the underwriter for the upcoming IPO. As Anew Health prepares for this significant financial event, the company’s leadership emphasizes its commitment to providing effective health solutions while expanding its market presence.
Anew Health operates from its headquarters located in Kowloon, Hong Kong at Unit 2301-05, 23/F, Tower 5, The Gateway Harbour City, 15 Canton Road, Tsim Sha Tsui. The company has a workforce of 245 employees, reflecting its established presence in the health sector.
For those interested in following the development of Anew Health and receiving updates, the company offers a subscription service via MarketBeat.com for daily news and ratings related to its operations and performance.
As Anew Health Ltd. moves forward with its IPO plans, the financial community will be watching closely to assess the implications for the company’s growth and its role in the evolving landscape of health services.
